Intravesical administration of Durvalumab to patients with high risk non muscle invasive bladder cancer who experience BCG failure. Final results from a phase II study by the Hellenic GU Cancer Group

Saved in:
Bibliographic Details
Published in:European urology 2024-03, Vol.85, p.S1716
Main Authors: Fragkoulis, C., Bamias, A., Gavalas, N., Tzannis, K., Fragkiadis, E., Pinitas, A., Stamatakos, P.V., Stathouros, G., Papadopoulos, G., Ntoumas, K., Stravodimos, K., Mitropoulos, D., Skolarikos, A., Papatsoris, A.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0302-2838
DOI:10.1016/S0302-2838(24)01312-5